Pilot Study of Resveratrol in Postmenopausal Women With High Body Mass Index.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Resveratrol (Primary)
- Indications Colorectal cancer
- Focus Pharmacodynamics
- 09 Oct 2014 Biomarkers information updated
- 09 Apr 2013 Planned number of patients changed from 40 to 34 as reported by ClinicalTrials.gov.
- 09 Apr 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.